Brigid Bio
Aberdeen
About Brigid Bio
Brigid Bio is a biotech company develops monoclonal antibody-based therapies for life-threatening & drug resistant fungal infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $212.7K
- Last round: Grant (Dec 2025)
- Website: brigidbio.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/brigid-bio-97926 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.